Valion Bio VBIO
NASDAQ VBIO
$0.54 +0.02 (+3.85%)
At close: Nov 13, 2026 · 4:00 PM EST

Valion Bio (VBIO) Asset Writedowns and Impairment (2021 - 2024)

Updated

Valion Bio (VBIO) recorded Asset Writedowns and Impairment of $338,000 in Q4 2024.

Analysis

Valion Bio (VBIO) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends

For FY2024, Valion Bio reported Asset Writedowns and Impairment of $354,000.

  • Across earlier years, Asset Writedowns and Impairment came in at $32,000 in FY2023 and -$8,000 in FY2021.
  • The Q4 2024 figure is the lowest quarterly Asset Writedowns and Impairment since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Valion Bio 73,008.00 -25.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 338,000.00
Jun 30, 2024 20,000.00
Mar 31, 2024 -4,000.00
Mar 31, 2021 -8,000.00
API Access

Valion Bio Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VBIO&period=max&api_key=YOUR_API_KEY